Inhaled fasudil and deta nonoate car-targeted liposomes for PAH

Ended Project Grant Awarded Last action

Award ID
R42HL151045
Recipient
Awarding agency
Obligated
$7,508,936

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Originally
Funding
  • $6,217,638.00 Federal
  • $1,291,298.00 Non-federal
Place of performance
North Carolina, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $1,006,870 $0
Amendment $1,006,870 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $1,291,298 $0
Amendment $1,291,298 $0
Amendment $1,291,298 $1,291,298
Amendment $0 $0
Amendment $0 $0
Amendment Inhaled fasudil and deta nonoate car-targeted liposomes for PAH - pulmonary arterial hypertension (PAH) affects ~15-50 individuals per million and claims… $0 $0
Original award $330,004 $0
Show all 13

Quick answers

Who received award R42HL151045?

R42HL151045 was awarded to Vascular Biosciences by National Heart Lung and Blood Institute (National Institutes of Health) on September 1, 2020.

How much is award R42HL151045 worth?

$7,508,936 has been obligated on R42HL151045: $6,217,638 in federal funding and $1,291,298 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award